• Users Online: 125
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents - Current issue
Coverpage
October-December 2018
Volume 1 | Issue 2
Page Nos. 53-84

Online since Tuesday, October 30, 2018

Accessed 3,868 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF
View as eBookView issue as eBook
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
EDITORIAL  

Being realistic and optimistic in curing cancer p. 53
Aung Naing
DOI:10.4103/JIPO.JIPO_20_18  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
REVIEW ARTICLES Top

Personalized cancer immunotherapy: Today's challenge and tomorrow's promise p. 56
Malaka Ameratunga, Wen Xu, Juanita Lopez
DOI:10.4103/JIPO.JIPO_13_18  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but serious adverse event p. 68
Abdulrazzak Zarifa, Mohammed Salih, Juan Lopez-Mattei, Hun Ju Lee, Cezar Iliescu, Saamir Hassan, Nicolas Palaskas, Jean-Bernard Durand, Elie Mouhayar, Joseph Kim, Peter Kim
DOI:10.4103/JIPO.JIPO_15_18  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
CASE REPORTS Top

Toxic epidermal necrolysis during cotherapy with ipilimumab and nivolumab p. 78
Shelby L Kubicki, Macartney E Welborn, Anisha B Patel
DOI:DOI: 10.4103/JIPO.JIPO_7_18  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Pyoderma gangrenosum following initiation of immune checkpoint inhibitor therapy p. 82
Macartney E Welborn, Shelby L Kubicki, Anisha B Patel
DOI:10.4103/JIPO.JIPO_11_18  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta